The Effects of Nitrate-Rich Mouthwash on Vascular Tone (NITRATONE)
The Short-Term Effects of Nitrate-Rich Mouthwash on Oral Bacterial Nitrite Production, Blood Pressure, and Nitrate and Nitrite Concentrations in Plasma and Saliva of Healthy Adults
High blood pressure (hypertension) is a major risk factor for cardiovascular disease. One important contributing factor to high blood pressure is reduced availability of nitric oxide (NO). Therefore, NO is an important molecule in maintaining healthy blood vessel function.
Dietary nitrate, found in leafy greens, can serve as an alternative source of nitric oxide in the body. After ingestion, nitrate is converted to nitrite by bacteria residing in the oral cavity. Nitrite can subsequently be converted to NO when swallowed. Therefore, this nitrate-nitrite-nitric oxide pathway is dependent on oral bacteria.
This study aims to assess whether rinsing the mouth with a nitrate-rich mouth rinse influences blood pressure in healthy adults. Also, concentrations of nitrate and nitrite in plasma and saliva will be measured following the nitrate-mouth rinse exposure.
Tutkimuksen yleiskatsaus
Tila
Ehdot
Yksityiskohtainen kuvaus
This study investigates the potential acute blood pressure lowering effects of a simple nitrate-rich mouth rinse and drink, while also monitoring their effects on oral nitrite production capacity (NPC), plasma and salivary nitrate and nitrite levels, oral pH levels and the oral microbiology.
The study is a short-term, double-blind, randomized, placebo-controlled, crossover trial.
Participants will receive interventions and donate samples at four separate sessions. At session (i), baseline measurements are taken prior to intervention, and samples are subsequently taken (as described under outcome measures). At session (i) and (ii), the participants will rinse the oral cavity with a nitrate-rich fluid (or placebo). Similarly for sessions (iii) and (iv), the participants will drink the same fluid (or placebo). When donating samples, the participants will be in fasting condition. In total there will be four sessions per participant with wash-out periods in-between.
To elucidate the short-term effects of the above-described interventions, sampling will be performed in the clinic at multiple time points during the first 2 hours after each intervention, as well as at 24 hours. Participants will also monitor their blood pressure at home at four different time points for all four interventions. No sampling or measurements will be performed during night-time.
For both the intervention and the placebo, potassium (K) salts are used (KNO3 and KCl). For chairside measurement of NPC in oral samples, the rapid Griess assay (RGA) will be used. Blood pressure will be measured at the study facilities as clinic blood pressure and orthostatic blood pressure (CBP and OBP, respectively) using a clinically validated blood pressure monitor. The same device will be used by the participants for home blood pressure measurements (HBP). Saliva pH will be measured using pH-sticks or a pH-meter. Plasma and saliva nitrate- and nitrite levels are analyzed using commercial laboratory kits. Salivary secretion rate (SCR) is recorded during saliva donation, and measured as volume per unit time. Microbiological effects will be analyzed with appropriate methods in the laboratory.
Opintotyyppi
Ilmoittautuminen (Arvioitu)
Vaihe
- Ei sovellettavissa
Yhteystiedot ja paikat
Opiskeluyhteys
- Nimi: Simeon KB Mavropoulos, DDS, MSc
- Puhelinnumero: +46766185930
- Sähköposti: simeon.mavropoulos@gu.se
Tutki yhteystietojen varmuuskopiointi
- Nimi: Amina Basic, PhD, DDS
- Puhelinnumero: +46766185930
- Sähköposti: amina.basic@gu.se
Opiskelupaikat
-
-
Västra Götaland County
-
Gothenburg, Västra Götaland County, Ruotsi, 41390
- Odontologen, University of Gothenburg
-
Ottaa yhteyttä:
- Amina Basic, DDS, PhD
- Puhelinnumero: +46766185930
- Sähköposti: amina.basic@gu.se
-
-
Osallistumiskriteerit
Kelpoisuusvaatimukset
Opintokelpoiset iät
- Aikuinen
- Vanhempi Aikuinen
Hyväksyy terveitä vapaaehtoisia
Kuvaus
Inclusion Criteria:
- ≥18 years of age; and
- clinic blood pressure <140/<90 mmHg.
Exclusion criteria:
- hypertension;
- systemic medication (other than the oral contraceptive pill);
- antibiotic treatment within the last 3 months;
- active smoking status and BMI > 30;
- prior gastric by-pass surgery;
- self-reported use of antiseptic mouthwash or toothpaste;
- self-reported use of tongue scrapes; and
- active periodontal disease or caries that needs treatment.
Opintosuunnitelma
Miten tutkimus on suunniteltu?
Suunnittelun yksityiskohdat
- Ensisijainen käyttötarkoitus: Perustiede
- Jako: Satunnaistettu
- Inventiomalli: Crossover-tehtävä
- Naamiointi: Nelinkertaistaa
Aseet ja interventiot
Osallistujaryhmä / Arm |
Interventio / Hoito |
|---|---|
|
Kokeellinen: Test mouth rinse
In this arm participants will receive nitrate rich-mouth rinse
|
The oral cavity is rinsed with nitrate from mouth rinse, rather than ingested.
Muut nimet:
|
|
Placebo Comparator: Placebo mouth rinse
In this arm participants will receive placebo mouth rinse
|
This mouth rinse is devoid of nitrates
This drink is devoid of nitrates
|
|
Active Comparator: Test drink
In this arm participants will receive nitrate-rich drink
|
Nitrate is ingested, rather than rinsed and spit out
Muut nimet:
|
|
Placebo Comparator: Placebo drink
In this arm participants will receive placebo drink
|
This mouth rinse is devoid of nitrates
This drink is devoid of nitrates
|
Mitä tutkimuksessa mitataan?
Ensisijaiset tulostoimenpiteet
Tulosmittaus |
Toimenpiteen kuvaus |
Aikaikkuna |
|---|---|---|
|
Blood pressure before and at regular intervals within the 24 hours after nitrate exposure.
Aikaikkuna: Baseline (prior to nitrate exposure) and during the 24 hours after nitrate exposure.
|
Blood pressure will be measured before and with regular intervals after nitrate exposure.
The measurements will be registered as systolic and diastolic measurements from clinic blood pressure and home blood pressure.
|
Baseline (prior to nitrate exposure) and during the 24 hours after nitrate exposure.
|
|
Oral nitrite production before and at regular intervals within the 24 hours after nitrate exposure.
Aikaikkuna: Baseline (prior to nitrate exposure) and during the 24 hours after nitrate exposure
|
The nitrite production is measured using the rapid Griess assay (RGA) - a chairside semi-quantitative nitrite concentration estimation tool for use in several different oral samples.
The RGA provides nitrite estimation on a grading scale of 0-5 with nitrite concentrations intervals.
|
Baseline (prior to nitrate exposure) and during the 24 hours after nitrate exposure
|
Toissijaiset tulostoimenpiteet
Tulosmittaus |
Toimenpiteen kuvaus |
Aikaikkuna |
|---|---|---|
|
Plasma and salivary nitrate and nitrite levels before and after nitrate exposure.
Aikaikkuna: Baseline (prior to nitrate exposure) and 1 hour after nitrate exposure.
|
Blood samples are drawn from venous blood before and 1 hour after nitrate exposure, and plasma is separated.
Saliva nitrate/nitrite is extracted from saliva samples donated before and 1 hour after nitrate exposure.
Both are analyzed using commercial laboratory kits.
|
Baseline (prior to nitrate exposure) and 1 hour after nitrate exposure.
|
|
Salivary pH levels at regular intervals.
Aikaikkuna: Baseline (prior to nitrate exposure) and during the 24 hours after nitrate exposure.
|
Salivary pH will be measured using a pH-stick at regular intervals before and after nitrate exposure.
|
Baseline (prior to nitrate exposure) and during the 24 hours after nitrate exposure.
|
|
Orthostatic blood pressure before and at regular intervals within the 24 hours after nitrate exposure.
Aikaikkuna: Baseline (prior to nitrate exposure) and during the 24 hours after nitrate exposure.
|
Orthostatic blood pressure will be measured at regular intervals before and after nitrate exposure and reported as systolic and diastolic blood pressure values in mmHg.
|
Baseline (prior to nitrate exposure) and during the 24 hours after nitrate exposure.
|
|
Salivary secretion rate before and after nitrate exposure.
Aikaikkuna: Baseline (prior to nitrate exposure) and during the 24 hours after nitrate exposure.
|
Salivary secretion rate will be registered as volume per unit time when donating saliva before and after nitrate exposure with regular intervals.
|
Baseline (prior to nitrate exposure) and during the 24 hours after nitrate exposure.
|
|
Relative abundance in cultivable oral microbial composition after nitrate exposure
Aikaikkuna: Baseline (prior to nitrate exposure) and during the 24 hours after nitrate exposure.
|
Microbial samples from multiple oral sites will be collected before and after nitrate exposure.
Oral microbial composition will be analyzed and reported as the relative abundance (%).
|
Baseline (prior to nitrate exposure) and during the 24 hours after nitrate exposure.
|
|
Absolute abundance in cultivable oral microbial composition after nitrate exposure
Aikaikkuna: Baseline (prior to nitrate exposure) and during the 24 hours after nitrate exposure.
|
Microbial samples from multiple oral sites will be collected before and after nitrate exposure.
Cultivable oral microbial composition will be analyzed and reported as absolute abundance and expressed as colony-forming units per milliliter (CFU/mL).
|
Baseline (prior to nitrate exposure) and during the 24 hours after nitrate exposure.
|
|
PCR detection of specific oral bacterial after nitrate exposure
Aikaikkuna: Baseline (prior to nitrate exposure) and during the 24 hours after nitrate exposure.
|
Microbial samples from multiple oral sites will be collected before and after nitrate exposure.
Quantitative PCR analysis will be performed for selected oral bacterial species and reported as bacterial counts or copy numbers.
|
Baseline (prior to nitrate exposure) and during the 24 hours after nitrate exposure.
|
|
Oral microbial metabolite concentrations after nitrate exposure
Aikaikkuna: Baseline (prior to nitrate exposure) and during the 24 hours after nitrate exposure.
|
Microbial samples from multiple oral sites will be collected before and after nitrate exposure.
Oral microbial metabolites will be analyzed and reported as metabolite concentration values.
|
Baseline (prior to nitrate exposure) and during the 24 hours after nitrate exposure.
|
Yhteistyökumppanit ja tutkijat
Sponsori
Tutkijat
- Päätutkija: Amina Basic, PhD, DDS, Göteborg University
Opintojen ennätyspäivät
Opi tärkeimmät päivämäärät
Opiskelun aloitus (Arvioitu)
Ensisijainen valmistuminen (Arvioitu)
Opintojen valmistuminen (Arvioitu)
Opintoihin ilmoittautumispäivät
Ensimmäinen lähetetty
Ensimmäinen toimitettu, joka täytti QC-kriteerit
Ensimmäinen Lähetetty (Todellinen)
Tutkimustietojen päivitykset
Viimeisin päivitys julkaistu (Todellinen)
Viimeisin lähetetty päivitys, joka täytti QC-kriteerit
Viimeksi vahvistettu
Lisää tietoa
Tähän tutkimukseen liittyvät termit
Avainsanat
Muut tutkimustunnusnumerot
- 2025-02639-01
Yksittäisten osallistujien tietojen suunnitelma (IPD)
Aiotko jakaa yksittäisten osallistujien tietoja (IPD)?
Lääke- ja laitetiedot, tutkimusasiakirjat
Tutkii yhdysvaltalaista FDA sääntelemää lääkevalmistetta
Tutkii yhdysvaltalaista FDA sääntelemää laitetuotetta
Nämä tiedot haettiin suoraan verkkosivustolta clinicaltrials.gov ilman muutoksia. Jos sinulla on pyyntöjä muuttaa, poistaa tai päivittää tutkimustietojasi, ota yhteyttä register@clinicaltrials.gov. Heti kun muutos on otettu käyttöön osoitteessa clinicaltrials.gov, se päivitetään automaattisesti myös verkkosivustollemme .